Literature DB >> 21569023

Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.

Harry T Chugani1, Ajay Kumar, William Kupsky, Eishi Asano, Sandeep Sood, Csaba Juhász.   

Abstract

PURPOSE: Interictal increase of (11) C-alpha-methyl-l-tryptophan (AMT) on positron emission tomography (PET) can be seen in cortical epileptic foci, and is particularly common in cortical developmental malformations. Therefore, in the present study, we evaluated the clinical and histopathologic correlates of AMT-PET abnormalities in children with intractable epilepsy undergoing resective surgery.
METHODS: Thirty children (mean age: 6.7 ± 3.2 years) were included in this study. All patients received AMT-PET as part of their presurgical evaluation and subsequently underwent epilepsy surgery. Magnetic resonance imaging (MRI) scans were normal in 15, showed nonspecific changes in 8, and suggested malformations of cortical development (MCDs) in nine children. Asymmetry indices (AIs) were calculated to determine increased AMT uptake. KEY
FINDINGS: Histopathology revealed MCDs in 16 (53%) children, including 12 with cortical dysplasia (CD) [mild MCD = 3; CD type IA = 2; CD type IIA = 2 and CD type IIB (severe CD with balloon cells) = 5]. Polymicrogyria and heterotopias (P&Hs) were seen in three cases and subependymal heterotopias (SEHs) in one child. The remaining 14 cases showed normal histopathology with varying degrees of gliosis. Increased AMT uptake was found in all five with CD type IIB, and all three with P&H, but in none with mild MCD and types IA-IIA CD or SEH. Whereas all five children with CD IIB and two with P&H had excellent surgical outcome (class I); children with milder CD or SEH had variable surgical outcome. The 14 patients with normal histopathology included seven patients with focally increased and seven with normal AMT uptake. Although patients with normal pathology and normal AMT-PET had better surgical outcome (class I = 5; II = 2), those with normal pathology, normal MRI, but abnormal AMT-PET had poor surgical outcome (class III = 4; IV = 3). SIGNIFICANCE: Increased AMT uptake in children with CD may predict type IIB dysplasia (with balloon cells) and good surgical outcome. Histopathologic similarities between CD type IIB and epileptogenic cortical tubers may imply a common role of the inflammatory kynurenine pathway of tryptophan metabolism in these lesions. In children with normal histopathology, there is a subgroup with increased AMT uptake and poor surgical outcome. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569023      PMCID: PMC3530921          DOI: 10.1111/j.1528-1167.2011.03103.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  37 in total

1.  Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex.

Authors:  E Asano; D C Chugani; O Muzik; C Shen; C Juhász; J Janisse; J Ager; A Canady; J R Shah; A K Shah; C Watson; H T Chugani
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias.

Authors:  Anand Iyer; Emanuele Zurolo; Wim G M Spliet; Peter C van Rijen; Johannes C Baayen; Jan A Gorter; Eleonora Aronica
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

3.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

4.  Type I focal cortical dysplasia: surgical outcome is related to histopathology.

Authors:  Laura Tassi; Rita Garbelli; Nadia Colombo; Manuela Bramerio; Giorgio Lo Russo; Francesco Deleo; Gloria Milesi; Roberto Spreafico
Journal:  Epileptic Disord       Date:  2010-07-27       Impact factor: 1.819

5.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 6.  Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Authors:  M W Taylor; G S Feng
Journal:  FASEB J       Date:  1991-08       Impact factor: 5.191

7.  Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme.

Authors:  F Yamazaki; T Kuroiwa; O Takikawa; R Kido
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

8.  Serotonin synthesis rate measured in living dog brain by positron emission tomography.

Authors:  M Diksic; S Nagahiro; T Chaly; T L Sourkes; Y L Yamamoto; W Feindel
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

9.  Daily variations of various parameters of serotonin metabolism in the rat brain. II. Circadian variations in serum and cerebral tryptophan levels: lack of correlation with 5-HT turnover.

Authors:  F Hery; G Chouvet; J P Kan; J F Pujol; J Glowinski
Journal:  Brain Res       Date:  1977-03-04       Impact factor: 3.252

10.  Identification of tryptophan 2,3-dioxygenase RNA in rodent brain.

Authors:  R Haber; D Bessette; B Hulihan-Giblin; M J Durcan; D Goldman
Journal:  J Neurochem       Date:  1993-03       Impact factor: 5.372

View more
  11 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  Neuroimaging of epilepsy.

Authors:  Fernando Cendes; William H Theodore; Benjamin H Brinkmann; Vlastimil Sulc; Gregory D Cascino
Journal:  Handb Clin Neurol       Date:  2016

Review 3.  α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.

Authors:  Ajay Kumar; Eishi Asano; Harry T Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 4.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

5.  Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.

Authors:  David O Kamson; Csaba Juhász; Amy Buth; William J Kupsky; Geoffrey R Barger; Pulak K Chakraborty; Otto Muzik; Sandeep Mittal
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

6.  Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.

Authors:  Bálint Alkonyi; Sandeep Mittal; Ian Zitron; Diane C Chugani; William J Kupsky; Otto Muzik; Harry T Chugani; Sandeep Sood; Csaba Juhász
Journal:  J Neurooncol       Date:  2011-11-03       Impact factor: 4.130

7.  Surface-based laminar analysis of diffusion abnormalities in cortical and white matter layers in neocortical epilepsy.

Authors:  Rajkumar Munian Govindan; Eishi Asano; Csaba Juhasz; Jeong-Won Jeong; Harry T Chugani
Journal:  Epilepsia       Date:  2013-02-28       Impact factor: 5.864

8.  Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus.

Authors:  Csaba Juhász; Amy Buth; Diane C Chugani; William J Kupsky; Harry T Chugani; Aashit K Shah; Sandeep Mittal
Journal:  Neurosurg Focus       Date:  2013-06       Impact factor: 4.047

9.  Evaluation of magnetic resonance imaging-negative drug-resistant epilepsy.

Authors:  Aashit K Shah; Sandeep Mittal
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

10.  TLR7 activation in epilepsy of tuberous sclerosis complex.

Authors:  Alan A Dombkowski; Daniela Cukovic; Shruti Bagla; McKenzie Jones; Joseph A Caruso; Harry T Chugani; Diane C Chugani
Journal:  Inflamm Res       Date:  2019-09-11       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.